semaglutide without gallbladder GLP-1 Therapy After Removal GLP-1 Without a Gallbladder |

A 2024 systematic review found digital tracking led to stronger weight-loss and maintenance outcomes than infrequent monitoring

95% CI: 0.23-0.40

If youve been at 0.25 mg or 0.5 mg for more than two months and arent seeing results, thats expected

PlexusDx recommends baseline micronutrient screening before or during the first month of compounded semaglutide to identify individual needs

Warning signs that require prompt assessment include: Persistent vomiting that prevents adequate fluid or medication intake Inability to maintain nutrition or hydration Severe abdominal pain (which could indicate pancreatitis, gallbladder disease, or other serious conditions) Vomiting of undigested food consumed many hours previously Significant unintended weight loss Worsening glycaemic control despite medication adherence It is worth noting that symptoms alone cannot definitively distinguish between expected medication effects and true gastroparesis